Using AI to Match Optimal Anti-Cancer Drugs to Cancer Patients – Interview with ImpriMed CEO Sungwon Lim
SKT Newsroom interviewed ImpriMed CEO Sungwon Lim regarding the development process of precision medicine solutions and the achievements from participating in the K-AI Alliance.
